Status:
COMPLETED
A Topical Desiccant Agent in Association With Manual Debridement in the Treatment of Peri-implant Mucositis
Lead Sponsor:
Universita di Verona
Conditions:
Peri-implant Mucositis
Eligibility:
All Genders
37-71 years
Phase:
NA
Brief Summary
In patients presenting peri-implant mucositis, effective sub-mucosal debridement is crucial to prevent peri-implantitis. The aim of this pilot study was to assess the 3-month clinical and microbiologi...
Detailed Description
A single-center, single-masked, parallel-groups, randomized clinical and microbiological study, was conducted between July and October 2018 at the Dentistry and Maxillo-facial Surgery Clinic, Departme...
Eligibility Criteria
Inclusion
- \- presence of at least one implant with a pocket probing depth (PPD) ≥ 4 mm, bleeding on probing (BOP) or pus on probing and no radiographically detectable bone loss (Qualifying site).
Exclusion
- pregnant or lactating females;
- patients with severe systemic diseases, or with uncontrolled diabetes mellitus;
- assumption of agents affecting the periodontal status within 1 month prior to the study;
- use of systemic antibiotics within 3 months prior to the study;
- prophylactic antibiotics requirement;
- peri-implant specific treatments within 6 months prior to the study;
- allergy to sulphates and its derivatives.
Key Trial Info
Start Date :
July 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2018
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT03858959
Start Date
July 1 2018
End Date
October 31 2018
Last Update
March 1 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Giorgio Lombardo
Verona, Italy, 37134